Premature cervical ripening is believed to contribute to preterm birth (PTB). Preterm cervical ripening may be due to an aberrant regulation in timing of the same processes that occur at term, or may result from unique molecular mechanisms. Using mouse models of PTB, this study sought to investigate if the molecular mechanisms that govern cervical ripening were similar between preterm and term. Lipopolysaccharide (LPS) is infused into the uterine horn to create a mouse model of inflammation-induced PTB. For a noninfectious model of PTB, RU486 was administered. Both models result in delivery of pups in 8-24 h. Cervical tissues were collected from these models, as well as throughout gestation. Cervical tissues from E15 (preterm), E15 LPS (preterm inflammation), and E18.5 (term) were used for microarray analysis (n ¼ 18). Additional experiments using gestational time course specimens were performed to confirm microarray results. Specific gene pathways were differentially expressed between the groups. Genes involved in immunity and inflammation were increased in the cervix in inflammation-induced PTB; term labor was not associated with differential expression of immune pathways. Cytokine expression was not increased in cervices during term labor, but was increased in the pospartum period. Epithelial cell differentiation pathway was significantly altered in term, but not preterm, labor. Activation of immune pathways may be sufficient for cervial ripening, but does not appear necessary. Differential expression of the epithelial cell differentiation pathway appears necessary in the process of cervical repair. Our results indicate that the molecular mechanisms governing preterm and term cervical ripening are distinctly different.
INTRODUCTION
Approximately 12.5% of all live births are preterm, an increase of 30% since 1981 [1] . Preterm birth (PTB) remains the leading cause of perinatal morbidity and mortality in developed countries, as well as a significant contributor to long-term adverse outcomes. About one in four extremely premature infants who survive have at least one major developmental disability. Hence, it is imperative that the mechanisms leading to PTB be elucidated to allow for successful therapies. Clinical and animal studies suggest that premature cervical shortening and/or premature cervical ripening contributes to, and, in fact, may be the initiator of, pathways leading to PTB.
Clinical studies have revealed that the risk of spontaneous preterm delivery is increased in patients who are found to have a short cervix by vaginal ultrasonography [2] . Results from these studies indicate that cervical ripening precedes myometrial contractions by several weeks, suggesting that the process is of long duration, and the latter is a late event in the pathogenesis of PTB [3] . The cervix is a metabolically active organ, composed of extracellular matrix (ECM) components, such as elastin, collagen, proteoglycans, hyaluronan, in addition to stromal, smooth muscle, and epithelial cells [4] . Cervical remodeling during pregnancy and parturition is a natural process of gradual remodeling of the connective tissue. This process of connective tissue remodeling is divided into four overlapping, but distinct, stages, which include softening, ripening, dilatation, and repair [3] . The normal process of cervical remodeling has been considered to be secondary to leukocytes, which invade the stromal matrix and release proteases that degrade collagen and components of the ECM [5] .
The regulation of cervical ripening and interactions between the cellular components, inflammatory cells, and ECM remains elusive [6] . It has been proposed that the earlier activation of the same key biochemical pathways accounting for term cervical ripening occur in preterm cervical ripening [7] . It is as yet unknown whether preterm cervical ripening is just an abnormal regulation in timing, or whether divergent mechanisms and pathways are involved in preterm versus term birth. Understanding these molecular mechanisms is imperative to comprehending the pathological states of preterm labor, as well as postterm pregnancy. We hypothesize that the molecular mechanisms and pathways involved in cervical ripening between preterm and term are analogous.
MATERIALS AND METHODS

Animals
CD1 outbred, timed-pregnant mice were purchased from Charles River Laboratories (Wilmington, MA). Animals were shipped on Days 8 and 12 after mating. Animals were acclimated in our facility for 3 or 7 days before use in these experiments. All the experiments were performed in accordance with the National Institute of Health Guidelines on Laboratory Animals and with approval from the University of Pennsylvania's Committee on Animal Use and Care.
Mouse Models of PTB
Two mouse models were utilized for these studies: a model of intrauterine inflammation, as previously described [8] [9] [10] [11] [12] , and a noninfectious model of PTB. For the mouse model of intrauterine inflammation, briefly, on Embryonic Day 15 (E15) of gestation, timed-pregnant CD1 dams were placed under isoflurane anesthesia. A minilaparotomy was performed, and the lower right uterine horn was identified. Lipopolysaccharide (LPS; Sigma, St. Louis, MO), 250 lg in a 100-ll volume, or sterile saline (100 ll) was infused between two gestational sacs, with care not to inject into the amniotic cavity. As previously reported, this model results in a high rate of PTB within 24 h, and does not result in maternal mortality [8] [9] [10] [11] [12] . In addition, this model is associated with preterm cervical ripening, as previously demonstrated [9, 13, 14] . In this model, cervical ripening is noted by an increase in cytokines, an influx of polymorphonuclear leukocytes, as well as histological evidence with increase in mucin and breakdown of cervical stroma. A noninfectious model of PTB was also utilized [15] . We confirmed that mifepristone (RU486; Sigma) reliably induced PTB in CD1 mice within 24 h (similar to our model of intrauterine inflammation), and does not induce maternal morbidity or mortality. RU486, 150 lg in a 100-ll volume, was diluted in dimethyl sulphoxide (Sigma) and administered subcutaneously in the neck region of each dam.
Cervical Tissues
For all studies, the cervix was identified, and adherent adipose, bladder, and rectum were carefully dissected off the cervical tissues. All cervical tissues were rinsed in sterile saline solution and then flash frozen until processed for molecular experiments described below.
Microarray Analysis
Cervical tissues for microarray were collected from six dams for each experimental group: 1) E15 dams with no intervention as preterm controls, 2) E15 harvested 6 h after intrauterine LPS infusion in the model of inflammationinduced PTB, 3) E18.5-19 selected from a timed-pregnant breeding, where half of the dams had delivered, representing term cervical ripening. Total RNA from each tissue was extracted with trizol (Invitrogen, Carlsbad, CA) and purified using Qiagen RNeasy kit (Qiagen, Valencia, CA). For all RNA specimens, 260/ 280 ratios were greater than 2.0. The cDNA was amplified using the WTOvation Pico RNA Amplification System (NuGEN Technologies, San Carlos, CA). The gene chip (one for each sample) mouse genome, 430V2 (Affymetrix, Santa Clara, CA), which contains over 39 000 mouse transcripts, was utilized to create CEL files, which are the Affymetrix data file format that contains hybridization intensities for each probe (25-mer) . Eighteen samples were hybridized to individual arrays, scanned, and processed by Affymetrix GeneChip Operating Software (GCOS), Version 1.4, producing CEL files with an individual probe intensity for each array. The microarray analysis was performed by the Bioinformatics Core at University of Pennsylvania. The GC robust multiarray average (gcrma) signal values were calculated from the CEL files using Stratagene ArrayAssist Lite v 3.4 (Stratagene, La Jolla, CA), producing CHP files, which contain the calculated signal intensity for each probe set signal (transcript) and AFFY (Affymetrix) flags. The CHP files were imported into Partek genomic suite V6.3b retaining genes flagged as present in at least 4 out of 18 samples. The data analyzed were log2-transformed gcrma signal values. In Partek, one-way ANOVA was performed across the three conditions, and three pair-wise comparisons performed to calculate P values and fold changes between each pair. For each P value we calculated, a corrected P value was generated using the false discovery rate technique of Benjamin-Hochberg, as implemented in Partek. Data were prioritized for follow-up based on P values. The genes to be confirmed by quantitative PCR (QPCR) and immunohistochemistry were selected based on P value and biological interest.
QPCR Analysis
Confirmatory QPCR analysis included cervical tissue specimens collected from the same experimental groups as used for microarray, as well as for the noninfectious PTB model and from gestational time course. For the noninfectious model, five dams per group were used. The gestational time course included cervical specimens collected from five different groups with three to six animals per group. The study groups were as follows: E15; E17; E18.5 and E19; Postpartum Days 0-1 (PP1); Postpartum Days 1-2 (PP2). Total RNA was extracted from cervical tissues with trizol (Invitrogen) and purified using Qiagen RNeasy mini kit (Qiagen), and cDNA was generated using highcapacity cDNA reverse transcription kit (Applied Biosystems, Foster City, CA). TaqMan gene expression assays, consisting of a 203 mix of unlabeled PCR primers and TaqMan minor groove binder probe, were purchased from Applied Biosystems. All TaqMan gene expression assays were performed using TaqMan Universal PCR Master Mix from Applied Biosystems. QPCR reactions were carried out using equivalent dilutions of each cDNA sample on the Applied Biosystems Model 7900 sequence detector PCR machine, as previously reported by our laboratory [8, 9] . To account for differences in starting material, QPCR was also carried out for each cDNA sample using primers to mouse 18S ribosomal RNA. These QPCR reactions defined a threshold cycle of detection for the target and RN18S in each cDNA sample. An arbitrary value of template was assigned to the highest standard and corresponding values to the subsequent dilutions, and these relative values were plotted against the threshold cycle value determined for each dilution to generate a standard curve. The relative abundance of the target of interest was divided by the relative abundance of RN18S in each sample to generate a standardized abundance for the target transcript of interest. All samples were analyzed in duplicate or triplicate. Mean target mRNA expression between all study groups was compared by one-way ANOVA or ANOVA on ranks if data were nonparametric. When significance was reached (P , 0.05), pair-wise comparison was performed by the Student-Newman-Keuls (SNK) method or the Dunn method.
Immunohistochemistry
Cervical tissues were harvested on E15 and E18 from timed-pregnant CD1 mice receiving no interventions. The resected cervix was fixed in 10% neutral buffered formalin for a minimum of 24 h. The specimens were embedded in paraffin. All immunohistochemical stains were performed on 5-lm sections from the paraffin blocks. The paraffin-embedded tissues were deparaffinated in xylene, rehydrated in ethanol, and then subjected to endogenous peroxide quenching. The tissues were heated to near boiling in citrate buffer for 20 min to retrieve antigen, and were pretreated with goat normal serum for 30 min. The primary antibody to desmoglein 1 was diluted in PBS, supplemented with 0.1% Tween and 5% of goat normal serum at a ratio of 1:50 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), and applied for 45 min. Two negative controls were performed. One with no antibody, and the other with whole rabbit serum at a ratio of 1:50. After washing thrice in PBS buffer, the biotinylated anti-rabbit IgG secondary antibody (Vectastain ABC kit; Vector Laboratories, Inc., Burlingame, CA) was used and then developed using diaminobenzidine (Sigma) according to the manufacturer's protocol. The tissues were counterstained with hematoxylin and dehydrated prior to mounting. Three E15 and three E18 specimens were stained with the primary antibody. Three or more specimens were used for each negative control. All photomicrographs were taken on a bright field microscope.
RESULTS
Microarray and Pathway Analysis
The single array represents 45 101 probe sets and 21 935 mouse genes, of which approximately 14 000 are well characterized. A total of 368 genes were identified as being differently regulated between the three groups in a least 4 of the 18 samples, and having a cut-off of 64-fold change with, a P value of ,0.0001. Principal component analysis (PCA) provides a useful exploratory technique for analysis of gene expression data. PCA allows for a graph depiction, in a 3D model, of whether the genes in the expression data set in an experimental condition cluster in distinct groups. PCA of the gene expression data revealed three distinct groups (Fig. 1) . Pathway analysis was performed by the use of the functional clustering tool in the Database for Annotation, Visualization, and Integrated Discovery (http://david.abcc.ncifcrf.gov/). For the gene list that had been input, we selected the first 1000 genes after sorting the genes by ascending step-up P value. The background gene list includes all genes on the Mouse Affymetrix Chip. Functional annotation clustering revealed the following pathways when comparing two of the groups: 1) term compared to preterm controls-negative regulation of cellular physiological process (enrichment score ¼ 2. 
Confirmation of Microarray by QPCR
Data from the microarray was prioritized based on P values. The most differentially regulated genes and those with biological plausibility were chosen for confirmation studies. QPCR confirmed the highly significant differences found in microarray for noted targets. The expression of cytokines, chemokine (C-X-C motif) ligand 10, S 100 calcium-binding protein A8 (previously known as calgranulin A), S 100 calcium-binding protein A9 (previously known as calgranulin B), and pentraxin-related gene was significantly up-regulated in the model of inflammation-induced PTB, which has a high preterm delivery rate (Table 1) . In contrast, despite delivery occurring with evident cervical ripening, the expression of these immune mediators is down-regulated in both the model of noninfectious PTB and at term ( Table 1) .
Investigation of Selected Pathways in Gestational Time Course
Our QPCR data were consistent with the microarray data, which revealed that the epithelial cell differentiation pathway was significantly up-regulated at term, and the proteins and pathways associated with inflammation were significantly upregulated in the model of inflammation-induced PTB. The genes involved in epithelial cell differentiation, specifically, keratin 8, desmoglein 1 alpha, and desmoglein 1 beta, were also increased in the noninfectious model, but to a lesser degree. In the model of inflammation-induced PTB, keratin 8, desmoglein 1 alpha, and desmoglein 1 beta mRNA were downregulated (Table 1) . To determine if these pathways are indeed specific to term cervical ripening, and if they could differentiate molecular mechanisms of preterm and term cerical ripening, we evaluated these targets in a gestational time course fashion, and in the noninfectious and inflammation models of PTB. Keratin 8, keratin 16, desmoglein 1 alpha, and desmoglein 1 beta mRNA expression was significantly different over the Results from QPCR are depicted, with each bar representing the mean 6 SD of mRNA from three to six specimens for each gestational age time point and treatment group. Keratin 8 was expressed differentially between each gestational age time point and treatment group (*one-way ANOVA, P 0.001). With pair-wise comparison (SNK method), expression on E18.5 was statistically significantly different from E15, E17, PP1, PP2, RU486, and E15 LPS (P , 0.05). Expression on E15 after RU486 was statistically significantly different from E15, E17, PP1, PP2, and E15 LPS (P , 0.05).
gestational time course (P , 0.001 for all targets) (Figs. 2-5 ). Desmoglein and keratin mRNA were found to be most profoundly increased on E18.5 and in the postpartum period. When comparing E18.5 to E15, higher mRNA expression of keratin 8 (3.8-fold), keratin 16 (329-fold), desmoglein1 alpha (37-fold), and desmoglein1 beta (19-fold) was observed (Figs.  2-5 ). In addition, when comparing PP1 to E15, keratin 16 (326-fold) and desmoglein1 beta (20-fold) message expression was profoundly increased (Figs. 3 and 5) .
To determine if the proteins and pathways associated with inflammation are indeed unique to inflammation-induced preterm cervical ripening, we evaluated specific targets in a gestational time course in the noninfectious model and inflammation-induced model of PTB. Tumor necrosis factor, interleukin 6, interleukin 1 beta, matrix metallopeptidase 2, matrix metallopeptidase 9, and tissue inhibitor of metalloproteinase 2 mRNA were differentially expressed between each gestational age time point and treatment group (P , 0.001 for all targets; Figs. 6 and 7). As expected, cytokine and matrix metallopeptidase expression is increased in the cervix in response to intrauterine inflammation. When comparing E15 Results from QPCR are depicted, with each bar representing the mean 6 SD of mRNA from three to six specimens for each gestational age time point and treatment group. Keratin 16 was expressed differentially between each gestational age time point and treatment group (*one-way ANOVA on ranks, P , 0.001). With pair-wise comparison (SNK method), expression on E18.5 was significantly higher than E15, E17, PP2, RU486, and E15 LPS (P , 0.05). In addition, the expression on PP1 was significantly higher than E15, E17, PP2, RU486, and E15 LPS (P , 0.05). Results from QPCR are depicted, with each bar representing the mean 6 SD of mRNA from three to six specimens for gestational age time point and treatment group. Desmoglein 1 alpha was expressed differentially between each gestational age time point and treatment group (*one-way ANOVA on ranks, P 0.001). With pair-wise comparison (SNK method), expression on E18.5 was significantly higher than E15, E17, PP2, RU486, and E15 LPS (P , 0.05). Results from QPCR are depicted, with each bar representing the mean 6 SD of mRNA from three to six specimens for each gestational age time point and treatment group. Desmoglein 1 beta was expressed differentially between each gestational age time point and treatment group (*one-way ANOVA on ranks, P 0.001). With pair-wise comparison (SNK method), expression on E18.5 was significantly higher than E15, E17, PP2, RU486, and E15 LPS (P , 0.05). In addition, the expression on PP1 was significantly higher than E15, E17, PP2, RU486, and E15 LPS (P , 0.05). Results from QPCR are depicted, with each bar representing the mean 6 SD of mRNA from three to six specimens for each gestational age time point and treatment group. TNF, IL6, and IL1beta were expressed differentially between each gestational age time point and treatment group (*one-way ANOVA on ranks, P 0.001). With pair-wise comparison (SNK method), Tnf expression on E15 LPS was significantly higher than E15, E17, E18.5, PP1, PP2, and RU486 (RU) (P , 0.001). In addition, the expression of Tnf on PP2 was significantly higher than E15, E17, E18.5, PP1, and RU486 (P , 0.001). With pair-wise comparison (SNK method), Il6 expression on E15 LPS was significantly higher than E15, E17, E18.5, PP1, PP2, and RU486 (P , 0.001). With pair-wise comparison (SNK method), Il1b expression on E15 LPS was significantly higher than E15, E17, E18.5, PP1, and RU486 (P , 0.05). In addition, the expression of Il1b on PP2 was significantly higher than E15, E17, E18.5, PP1, and RU486 (P , 0.001). 4-fold) , and Mmp9 (1.95-fold) were significantly increased (Figs. 6 and  7) . No increase in the cytokines or matrix metallopeptidases expression was observed in term cervices. When comparing E18.5 (term) and E15 (preterm), no statistically significant changes in mRNA expression for Tnf, Il6, Il1b, and Mmp9 were observed. In addition, Mmp2 mRNA expression was significantly lower when comparing E18.5 to E15 (À2.03-fold) (Figs. 6 and 7) . In contrast, some of these cytokines and matrix metallopeptidases were increased not at term, but in the postpartum period. When comparing PP2 to E18.5, mRNA expression was significantly higher for Tnf (10.3-fold), Il1b (43.6-fold), and Mmp9 (4.65-fold) (Figs. 6 and 7) .
LPS to
E15, mRNA expression of Tnf (13.01-fold), Il6 (323.72-fold), Il1b (138.56-fold), Mmp2 (1.
Immunohistochemistry
Given that the desmoglein 1 mRNA expression was significantly up-regulated at term, immunohistochemical detection of desmoglein 1 was performed on cervical tissue. There is significant expression of desmoglein 1 in the stromal region and cervical epithelium in E18 compared with E15, confirming an alteration in both message expression and protein (Fig. 8) . No staining was observed in the negative controls with no antibody and whole rabbit serum.
DISCUSSION
Our data support that the molecular mechanisms and pathways governing preterm and term cervical ripening are distinctly heterogeneous and diverse. Regardless of the timing during gestation (preterm or term), it has been considered that the normal process of cervical remodeling is mediated by the inflammatory cascade [16] . In this process, it is postulated that the leukocytes invade the stromal matrix and release proteases that degrade ECM components and collagen [17] . In contrast, our data demonstrate that activation of inflammatory pathways FIG. 7 . Matrix metallopeptidases and tissue inhibitor of metalloproteinase (Timp) 2 mRNA expression in the cervix throughout mouse gestation and in the noninfectious and inflammation model of PTB. Results from QPCR are depicted, with each bar representing the mean 6 SD of mRNA from three to six specimens for each gestational age time point and treatment group. Mmp2, Mmp9, and Timp2 were expressed differentially between each gestational age time point and treatment group (*one-way ANOVA on ranks, P 0.001). With pair-wise comparison (SNK method), Mmp2 expression on E15 LPS was significantly higher than E15, E17, E18.5, PP1, PP2, and RU486 (RU) (P , 0.05). In addition, the expression of Mmp2 on E15 was significantly higher than E17, E 18.5, PP1, and PP2 (P , 0.05). With pair-wise comparison (SNK method), Mmp9 expression on E 15 LPS was significantly higher than E15, E17, E18.5, PP1, PP2, and RU486 (P , 0.05). In addition, the expression of Mmp9 on PP2 was significantly higher than E15, E17, E18.5, PP1, and RU486 (P , 0.05). With pair-wise comparison (SNK method), Timp2 expression on E15 LPS was significantly higher than E17, E18.5, PP1, PP2, and RU486 (P , 0.05). In addition, the expression of Timp2 on E15 was significantly higher than E17, E18.5, PP1, PP2, and RU486 (P , 0.05). 
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are not essential for cervical ripening, as these pathways are not differentially regulated in the noninfectious model of PTB or with term parturition. Some investigators have found that noninfected preterm and term cervical ripening is an inflammatory process, with cytokines being an important mediator [16] . The cervical biopsies for several of these clinical studies were obtained postpartum. Our work, in contrast, agrees with recent work of others [18] in challenging the essential role of inflammation in the process of term cervical ripening. In these studies, we demonstrate that cytokines and the matrix metallopeptidases are not increased in term cervical ripening, they are only increased in inflamamtion-induced PTB. Our observations are consistent with a unique mouse model of cervical remodeling that fails to undergo parturition despite a large influx of leukocytes [19] . Other studies in mice support that cervical ripening does not require activation of a typical inflammatory response, given that macrophages, eosinophils, myeloperoxidase activity, and the expression of proinflammatory molecules are not increased within the cervix until after birth [18] . Human studies report that granulocytes and IL8 concentrations are increased postpartum, and not during cervical ripening [20, 21] . Consistent with these studies, we found that the cytokines and metallopeptidases are increased postpartum, suggesting that the inflammatory respose may facilitate repair of the cervix after delivery. Others have suggested that this process would ensure protection of the entire reproductive tract from microbial infection, and assure the ability to initiate and maintain future pregnancies [22] .
While inflammatory pathways may not be necessary for the process of cervical ripening, the inflammatory pathways are indeed sufficient for cervical ripening to occur. We found a significant up-regulation of the levels of S100a8 and S100a9 mRNA in the cervix in the setting of inflammation-induced PTB. These two calcium-binding proteins heterodimerize to form a protein complex that is highly expressed in tissues involved in active inflammatory disease [23] . Women in labor secondary to intra-amniotic inflammation have been found to have increased S100a8 and S100a9 in amniotic fluid and blood [24] [25] [26] . Our work demonstrates that host immune pathways leading to inflammation are unique to PTB, and are not an end or final pathway of cervical ripening. While they may be nonessential for cervical ripening, targeting these pathways for the prevention of spontaneous PTB in human should be pursued.
The cervix serves as a barrier to invading microorganisms, protecting the upper reproductive tract and fetus from infection during pregnancy [27] . In human pregnancies, the loss of cervical competency could lead to a compromise of the protective functions of the cervix. This process could facilitate ascending infection, leading to the release of inflammatory mediators, inducing further preterm cervical remodeling, leading to PTB. The molecular and biological mechanisms by which cervical competency is lost remain elusive. One possible mechanism for the loss of cervical competency is a deregulation in the epithelial cell differentiation pathway. Our microarray data revealed that the epithelial cell differentiation pathway was significantly up-regulated at term, but not preterm. This pathway is of particular interest and importance, given its critical functions in the cervical epithelia, which include, but are not limited to, remodeling in preparation for parturition, maintenance of fluid balance, protection from infection, and maintenance of a permeability barrier that regulates paracellular transport [28] . Intracellular junctions regulate the critical barrier properties of the epithelia, and they have been associated to epithelial differentiation and apoptosis. Mechanisms regulating these processes remain poorly defined.
Desmosomes are critical elements of intercellular junctions, and are made up of transmembrane desmosomal cadherins, termed desmoglein and desmocollin [29] . The desmosomal cadherins are linked to the keratin cytoskeleton via several cytoplasmic plaque proteins, and provide mechanical strength to the epithelia [30] . To our knowledge, the involvement of desmogleins in the cervical remodeling process has not been reported. Data suggest that the function of desmosomes is much more complicated than simple cell adhesion. Desmosomal molecules are important in development and differentiation [31, 32] . It has been demonstrated that inappropriate expression of desmoglein in the upper epidermis results in abnormal differentiation and barrier defects [33, 34] . Consistent with our data, genes that play a role in epithelial differentiation and barrier function-specifically, keratinhave been reported to be increased during cervical ripening, but are further increased during cervical dilatation/postpartum repair [35] . Our data support that activation of the epithelial cell differentiation pathway is not necessary for inflammationinduced preterm cervical ripening. In contrast, the upregulation of this pathway at term and postpartum suggests involvement in the process of cervical remodeling-specifically, postpartum repair. Epidemiological studies have demonstrated that the risk of a subsequent PTB rises as the number of prior PTBs increases, and it declines with each birth that is not preterm. Our findings in conjunction with this epidemiological data introduce the biological plausibility that a lack of appropriate cervical remodeling may be a risk factor for recurrent PTB. These observations require further consideration.
These studies have limitations. The unidentified differences between mice and humans in regard to cervical remodeling and PTB must be considered. Our results do not permit the detemination of whether the changes observed in mRNA expression in cervical tissue have a functional significance. However, the process of cervical remodeling must be conserved across mammalian species, as it is an obligatory process to allow for parturition and continuation of the species. The use of mice to investigate these pathways affords insights into these processes. Our use of two models and gestational time course add strength and validtity to our findings. Understanding of the process of cervical remodeling is imperative in order to comprehend causes of PTB and postterm birth in which abnormal cervical function is the culprit.
